共 9 条
[1]
Single agent oral vinorelbine (NVB) in advanced non-small cell lung cancer (NSCLC) in the elderly: Patient benefit improvement by weekly schedule. Mail P,Marinis FD,Manegold C,et al. ASCO Pro . 2004
[2]
Management of elderly lung cancer patients in France; A national prospective survey by the French intergroup of thoracic oncology (IFCT). Lebitasy MP,Monnet L,Depierre A,et al. ASCO Pro . 2004
[3]
Neoadjuvant chemoradiotherapy by surgery in eldery patients with locally advanced non-amall cell lung cancer: Analysis of feasibility, tox-icity and factors predicting surgical resection and survival. D’Angelillo RM,Trodella L,Ramella S,et al. AS-CO Pro . 2004
[4]
Comparative retrospective study between brs supportive care (BSC) versus chemotherapy for elderly patients with NSCLC. Katz AV,Arruda MT,Yamaguchi JY,et al. ASCO Pro . 2004
[5]
Non small cell lung cancer (NSCLC): Are elderly patients being under-treated. Ng R,Boer RD,Park A,et al. ASCO Pro . 2004
[6]
Gefitinib (ZD1839) comined with gemcitabine or vinorelbine as single-agent in elderly patients with advanced non-small cell lung cancer (NSCLC). Scagliotti G,Rossi A,Novelo S,et al. ASCO Pro . 2004
[7]
A combination chemotherapy of carboplatin and irinotecan in elderly patients with small cell lung cancer (SCLC). Okamoto H,Kudoh H,Nagatomo A,et al. ASCO Pro . 2004
[8]
Ten-year survey of lung cancer treatment and survival in hospitals in United States. Fry W,Phillips,Menck H. Cancer . 1999
[9]
Effects of vinorelbine on quality of life and survival of elderly patients with adbanced non-small-cell lung cancer. The elderly lung cancer vinorelbine Italian study group. Journal of the National Cancer Institute . 1999